NCT03882931

Brief Summary

Dorsolateral prefrontal cortex (DLPFC) has been found to be involved in cognitive functions such as executive function, response selection, and working memory. By applying transcranial magnetic stimulation (TMS) or transcranial focused ultrasound (FUS), which is a technology to temporally alter brain state in the stimulation site, the investigators aim to find supporting evidence for the causal relationship between the targeted stimulation site and motor learning improvement or response selection.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
90

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jan 2019

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 28, 2019

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

March 19, 2019

Completed
1 day until next milestone

First Posted

Study publicly available on registry

March 20, 2019

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 27, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 27, 2020

Completed
Last Updated

November 19, 2019

Status Verified

November 1, 2019

Enrollment Period

12 months

First QC Date

March 19, 2019

Last Update Submit

November 17, 2019

Conditions

Keywords

Dorsolateral Prefrontal CortexNeuromodulationTranscranial Magnetic StimulationTranscranial Ultrasound Stimulation

Outcome Measures

Primary Outcomes (1)

  • Performance Error on Visuomotor Task

    The visuomotor task has practice, baseline, and experimental trials. Performance on the task will be compared between groups.

    immediately following baseline assessment

Study Arms (4)

TMS to left DLPFC

EXPERIMENTAL

Theta Burst Transcranial Magnetic Stimulation will be delivered at 80% of the participants motor threshold to the left DLPFC and complete a visuomotor rotation task.

Other: Theta Burst Transcranial Magnetic Stimulation

TMS to right DLPFC

EXPERIMENTAL

Theta Burst Transcranial Magnetic Stimulation will be delivered at 80% of the participants motor threshold to the right DLPFC and complete a visuomotor rotation task.

Other: Theta Burst Transcranial Magnetic Stimulation

TMS Control

SHAM COMPARATOR

A Sham Theta Burst Transcranial Magnetic Stimulation will be delivered to the right/left DLPFC and complete a visuomotor rotation task.

Other: Sham

FUS to right/left DLPFC

EXPERIMENTAL

Low intensity Focused Ultrasound stimulation will be delivered to either the left or right DLPFC depending on the subject's DLPFC response during their functional MRI flanker task.

Other: Focused Ultrasound

Interventions

Theta Bursts are short bursts of stimulation at high frequencies, which are applied 5 times per second

TMS to left DLPFCTMS to right DLPFC

Low intensity focused ultrasound is sound energy stimulation at a low intensity of 1-30 W/cm2

FUS to right/left DLPFC
ShamOTHER

The investigators will simulate theta bursts pulses similar to the Theta Burst Transcranial Magnetic Stimulation groups but without stimulation.

TMS Control

Eligibility Criteria

Age18 Years - 35 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Healthy, adult subjects
  • to 35 years of age
  • Right-handed
  • Have no any type of metal in the body
  • Provide written informed consent

You may not qualify if:

  • Presence of a significant medical, psychiatric, or neurologic illness
  • History of loss of consciousness of more than ten minutes in the past year or loss of consciousness in a lifetime that required rehabilitation services
  • Personal or family history of seizure
  • Any history of stroke/transient ischemic attack (TIA) or severe traumatic brain injury
  • Taking any medications that may decrease the threshold for seizure
  • Pregnancy (self-reported)
  • Affirmative answers to one or more questions of the provided attached safety questionnaires. These are not absolute contraindications to this study but the risk/benefit ratio will be carefully balanced by the PI
  • Failure to follow laboratory or study procedures

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Virginia

Charlottesville, Virginia, 22903, United States

RECRUITING

MeSH Terms

Interventions

salicylhydroxamic acid

Study Officials

  • Wynn Legon, PhD

    University of Virginia

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Masking Details
Participants receiving ultrasound stimulation will be blinded to the type of ultrasound stimulation they are receiving.
Purpose
BASIC SCIENCE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 19, 2019

First Posted

March 20, 2019

Study Start

January 28, 2019

Primary Completion

January 27, 2020

Study Completion

January 27, 2020

Last Updated

November 19, 2019

Record last verified: 2019-11

Locations